Eli Lilly

Could Eli Lilly and Precision BioSciences Make Breakthroughs for DMD?
Could Eli Lilly and Precision BioSciences Make Breakthroughs for DMD?
BioSpace
Eli Lilly
Precision Biosciences
Duchenne Muscular Dystrophy
Flag link:
Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus remdesivir combo
Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus remdesivir combo
Endpoints
Eli Lilly
FDA
COVID-19
Emergency Use Authorization
olumiant
remdesivir
Flag link:
Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up
Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up
Endpoints
AbCellera
Eli Lilly
Regeneron
Trianni
monoclonal antibodies
Flag link:
How Effective Will Lilly’s Bamlanivimab be in the Battle Against COVID-19?
How Effective Will Lilly’s Bamlanivimab be in the Battle Against COVID-19?
BioSpace
Eli Lilly
bamlanivimab
LY-CoV555
COVID-19
antibodies
Flag link:
Shortage of monkeys slowed down Eli Lilly's Covid-19 antibody partner. And it's a problem for everyone
Shortage of monkeys slowed down Eli Lilly's Covid-19 antibody partner. And it's a problem for everyone
Endpoints
COVID-19
animal studies
clinical trials
antibodies
Eli Lilly
Shanghai Junshi Biosciences
Flag link:
Lilly backs a biotech's spinout and places a small bet on protein degradation
Lilly backs a biotech's spinout and places a small bet on protein degradation
BioPharma Dive
Eli Lilly
Seed Therapeutics
protein degradation
Flag link:
Eli Lilly Designs P-Tau Biomarker Assay for Early Alzheimer’s Disease Diagnosis
Eli Lilly Designs P-Tau Biomarker Assay for Early Alzheimer’s Disease Diagnosis
BioSpace
Eli Lilly
Alzheimer's disease
biomarker assays
biomarkers
diagnostics
P-tau
Flag link:
Feds Will Start Distributing Eli Lilly Covid-19 Antibody Treatment This Week
Feds Will Start Distributing Eli Lilly Covid-19 Antibody Treatment This Week
Forbes
HHS
Alex Azar
antibodies
COVID-19
Eli Lilly
Flag link:
Eli Lilly gets FDA EUA status for bamlanivimab to treat Covid-19
Eli Lilly gets FDA EUA status for bamlanivimab to treat Covid-19
Pharmaceutical Business Review
Eli Lilly
Emergency Use Authorizations
FDA
LY-CoV-55
COVID-19
antibodies
Flag link:
After Pfizer's vaccine data, analysts say COVID19 drugmakers face questions about long-term sales prospects
After Pfizer's vaccine data, analysts say COVID19 drugmakers face questions about long-term sales prospects
Fierce Pharma
Pfizer
BioNTech
Gilead Sciences
Eli Lilly
Regeneron
COVID-19
pharma stocks
vaccines
clinical trials
Flag link:
Why AstraZeneca, Bristol Myers Squibb, and Eli Lilly Stocks Jumped Today
Why AstraZeneca, Bristol Myers Squibb, and Eli Lilly Stocks Jumped Today
Motley Fool
pharma stocks
2020 Presidential election
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Flag link:
EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis
EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Yahoo
Eli Lilly
Incyte
baricitinib
atopic dermatitis
EADV
Flag link:
Eli Lilly lines up a blockbuster deal for Covid-19 antibody, right after it failed a NIAID trial
Eli Lilly lines up a blockbuster deal for Covid-19 antibody, right after it failed a NIAID trial
Endpoints
Eli Lilly
antibodies
COVID-19
FDA
government contract
Flag link:
Care Access Research, Lilly join on mobile COVID-19 trials
Care Access Research, Lilly join on mobile COVID-19 trials
Biopharma Reporter
Eli Lilly
Care Access Research
COVID-19
clinical trials
Flag link:
Eli Lilly Ends Covid-19 Antibody Trial After Finding It’s Unlikely To Help Hospitalized Patients
Eli Lilly Ends Covid-19 Antibody Trial After Finding It’s Unlikely To Help Hospitalized Patients
Forbes
Eli Lilly
antibodies
COVID-19
clinical trials
Flag link:
Eli Lilly may face FDA warning letter after recent inspection at COVID-19 antibody plant found more issues: report
Eli Lilly may face FDA warning letter after recent inspection at COVID-19 antibody plant found more issues: report
Fierce Pharma
Eli Lilly
COVID-19
antibodies
drug manufacturing
FDA
Flag link:
Eli Lilly strikes deal to sell R&D campus to UCB
Eli Lilly strikes deal to sell R&D campus to UCB
Fierce Biotech
Eli Lilly
R&D
UK
UCB Pharma
Flag link:
Eli Lilly Acquires Disarm Therapeutics in an Effort to Solve Axonal Degeneration
Eli Lilly Acquires Disarm Therapeutics in an Effort to Solve Axonal Degeneration
BioSpace
Eli Lilly
axonal degeneration
M&A
Disarm Therapeutics
Flag link:
What The Pause In The Johnson & Johnson And Eli Lilly Covid Drug Trials May Mean
What The Pause In The Johnson & Johnson And Eli Lilly Covid Drug Trials May Mean
Forbes
vaccines
JNJ
Eli Lilly
COVID-19
clinical trials
Flag link:
Eli Lilly faces FDA crackdown for manufacturing issues at plant handling COVID-19 antibody
Eli Lilly faces FDA crackdown for manufacturing issues at plant handling COVID-19 antibody
Fierce Pharma
Eli Lilly
FDA
drug manufacturing
antibodies
COVID-19
Flag link:

Pages